Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Engineered T Cells Market Status and Forecast (2016-2027)
1.3.2 Global Engineered T Cells Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Engineered T Cells Supply by Company
2.1 Global Engineered T Cells Sales Value by Company
2.2 Engineered T Cells Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Engineered T Cells Market Status by Type
3.1 Engineered T Cells Type Introduction
3.1.1 Tumor Infiltrating Lymphocytes
3.1.2 T Cell Receptor {TCR}
3.1.3 Chimeric Antigen Receptor(CAR)
3.2 Global Engineered T Cells Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Engineered T Cells Market Status by Application
4.1 Engineered T Cells Segment by Application
4.1.1 Hospitals
4.1.2 Cancer Research Centers
4.1.3 Clinics
4.2 Global Engineered T Cells Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Engineered T Cells Market Status by Region
5.1 Global Engineered T Cells Market by Region
5.2 North America Engineered T Cells Market Status
5.3 Europe Engineered T Cells Market Status
5.4 Asia Pacific Engineered T Cells Market Status
5.5 Central & South America Engineered T Cells Market Status
5.6 Middle East & Africa Engineered T Cells Market Status
6 North America Engineered T Cells Market Status
6.1 North America Engineered T Cells Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Engineered T Cells Market Status
7.1 Europe Engineered T Cells Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Engineered T Cells Market Status
8.1 Asia Pacific Engineered T Cells Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Engineered T Cells Market Status
9.1 Central & South America Engineered T Cells Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Engineered T Cells Market Status
10.1 Middle East & Africa Engineered T Cells Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Engineered T Cells Market Forecast by Type and by Application
12.1 Global Engineered T Cells Sales Value Forecast (2022-2027)
12.2 Global Engineered T Cells Forecast by Type
12.3 Global Engineered T Cells Forecast by Application
13 Global Engineered T Cells Market Forecast by Region/Country
13.1 Global Engineered T Cells Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Unum Therapeutics
14.1.1 Company Information
14.1.2 Engineered T Cells Product Introduction
14.1.3 Unum Therapeutics Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Seeking Alpha
14.2.1 Company Information
14.2.2 Engineered T Cells Product Introduction
14.2.3 Seeking Alpha Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Redmile Group
14.3.1 Company Information
14.3.2 Engineered T Cells Product Introduction
14.3.3 Redmile Group Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Precision Bioscience
14.4.1 Company Information
14.4.2 Engineered T Cells Product Introduction
14.4.3 Precision Bioscience Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Pfizer
14.5.1 Company Information
14.5.2 Engineered T Cells Product Introduction
14.5.3 Pfizer Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Oxford Biomedica
14.6.1 Company Information
14.6.2 Engineered T Cells Product Introduction
14.6.3 Oxford Biomedica Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Novartis
14.7.1 Company Information
14.7.2 Engineered T Cells Product Introduction
14.7.3 Novartis Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Juno Therapeutics
14.8.1 Company Information
14.8.2 Engineered T Cells Product Introduction
14.8.3 Juno Therapeutics Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Gilead Sciences
14.9.1 Company Information
14.9.2 Engineered T Cells Product Introduction
14.9.3 Gilead Sciences Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Elli Lilly and Company
14.10.1 Company Information
14.10.2 Engineered T Cells Product Introduction
14.10.3 Elli Lilly and Company Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Cells Medica
14.12 Bellicum Pharmaceuticals
14.13 Autolus Limited
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Engineered T Cells Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Engineered T Cells Sales Value (Million USD) by Company (2019-2021)
Table Global Engineered T Cells Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Engineered T Cells Sales Area
Table Engineered T Cells Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Engineered T Cells Sales Value (Million USD) by Type (2016-2021)
Table Global Engineered T Cells Sals Value Market Share by Type (2016-2021)
Table North America Engineered T Cells Sales Value (Million USD) by Type (2016-2021)
Table North America Engineered T Cells Sales Value Market Share by Type (2016-2021)
Table Europe Engineered T Cells Sales Value (Million USD) by Type (2016-2021)
Table Europe Engineered T Cells Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Engineered T Cells Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Engineered T Cells Sales Value Market Share by Type (2016-2021)
Table Central & South America Engineered T Cells Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Engineered T Cells Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Engineered T Cells Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Engineered T Cells Sales Value Market Share by Type (2016-2021)
Table Global Engineered T Cells Sales Value (Million USD) by Application (2016-2021)
Table Global Engineered T Cells Value Market Share by Application (2016-2021)
Table North America Engineered T Cells Sales Value (Million USD) by Application (2016-2021)
Table North America Engineered T Cells Sales Value Market Share by Application (2016-2021)
Table Europe Engineered T Cells Sales Value (Million USD) by Application (2016-2021)
Table Europe Engineered T Cells Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Engineered T Cells Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Engineered T Cells Sales Value Market Share by Application (2016-2021)
Table Central & South America Engineered T Cells Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Engineered T Cells Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Engineered T Cells Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Engineered T Cells Sales Value Market Share by Application (2016-2021)
Table Global Engineered T Cells Sales Value (Million USD) by Region (2016-2021)
Table Global Engineered T Cells Value Market Share by Region (2016-2021)
Table North America Engineered T Cells Sales Value (Million USD) by Country (2016-2021)
Table North America Engineered T Cells Value Market Share by Country (2016-2021)
Table Europe Engineered T Cells Sales Value (Million USD) by Country (2016-2021)
Table Europe Engineered T Cells Value Market Share by Country (2016-2021)
Table Asia Pacific Engineered T Cells Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Engineered T Cells Value Market Share by Country (2016-2021)
Table Central & South America Engineered T Cells Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Engineered T Cells Value Market Share by Country (2016-2021)
Table Middle East & Africa Engineered T Cells Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Engineered T Cells Value Market Share by Country (2016-2021)
Table Global Engineered T Cells Value (Million USD) Forecast by Type (2022-2027)
Table Global Engineered T Cells Value Market Share Forecast by Type (2022-2027)
Table Global Engineered T Cells Value (Million USD) Forecast by Application (2022-2027)
Table Global Engineered T Cells Value Market Share Forecast by Application (2022-2027)
Table Global Engineered T Cells Value (Million USD) Forecast by Region (2022-2027)
Table Global Engineered T Cells Value Market Share Forecast by Region (2022-2027)
Table Unum Therapeutics Company Information
Table Unum Therapeutics Product Introduction
Table Unum Therapeutics Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Seeking Alpha Company Information
Table Seeking Alpha Product Introduction
Table Seeking Alpha Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Redmile Group Company Information
Table Redmile Group Product Introduction
Table Redmile Group Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Precision Bioscience Company Information
Table Precision Bioscience Product Introduction
Table Precision Bioscience Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Pfizer Company Information
Table Pfizer Product Introduction
Table Pfizer Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Oxford Biomedica Company Information
Table Oxford Biomedica Product Introduction
Table Oxford Biomedica Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Novartis Company Information
Table Novartis Product Introduction
Table Novartis Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Juno Therapeutics Company Information
Table Juno Therapeutics Product Introduction
Table Juno Therapeutics Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Gilead Sciences Company Information
Table Gilead Sciences Product Introduction
Table Gilead Sciences Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)
Table Elli Lilly and Company Company Information
Table Elli Lilly and Company Product Introduction
Table Elli Lilly and Company Engineered T Cells Sales Value, Gross Margin and Global Share (2019-2021)